Literature DB >> 11693175

Expression of the MT1 melatonin receptor subtype in human coronary arteries.

C Ekmekcioglu1, P Haslmayer, C Philipp, M R Mehrabi, H D Glogar, M Grimm, V J Leibetseder, T Thalhammer, W Marktl.   

Abstract

Previous experimental data suggest a possible influence of melatonin on the circulatory system of animals after binding to G-protein coupled melatonin receptors. The present study sought to investigate whether the melatonin receptor, mt1, is expressed in human coronary arteries derived from healthy heart donors (n = 8). Expression of the mt1-receptor was studied in sections of isolated coronary arteries by a reverse transcriptase-polymerase chain reaction (RT-PCR) and Western immunoblot technique. The analyses of the results from both methods indicated the presence of the mt1-receptor in all of the subjects. Referring to these data we assume that melatonin regulates physiological processes in human coronary arteries after receptor binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693175     DOI: 10.1081/rrs-100107144

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  11 in total

Review 1.  Expression and putative functions of melatonin receptors in malignant cells and tissues.

Authors:  Cem Ekmekcioglu
Journal:  Wien Med Wochenschr       Date:  2014-07-15

Review 2.  Melatonin receptors: molecular pharmacology and signalling in the context of system bias.

Authors:  Erika Cecon; Atsuro Oishi; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

3.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

4.  Melatonin MT2 receptor is expressed and potentiates contraction in human airway smooth muscle.

Authors:  Haruka Sasaki; Yi Zhang; Charles W Emala; Kentaro Mizuta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-06       Impact factor: 5.464

Review 5.  Effects of circadian disruption on the cardiometabolic system.

Authors:  Melanie Rüger; Frank A J L Scheer
Journal:  Rev Endocr Metab Disord       Date:  2009-12       Impact factor: 6.514

6.  Melatonin inhibits nitrate tolerance in isolated coronary arteries.

Authors:  Stephen T O'Rourke; Hana Hammad; Philippe Delagrange; Elizabeth Scalbert; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

7.  The effect of melatonin on plasma markers of inflammation and on expression of nuclear factor-kappa beta in acetic acid-induced colitis in the rat.

Authors:  Hayam G Sayyed; Rumi J Jaumdally; Naglaa K Idriss; Dalia A El Sers; Andrew Blann
Journal:  Dig Dis Sci       Date:  2013-08-08       Impact factor: 3.199

8.  Sleep Medications Containing Melatonin can Potentially Induce Ventricular Arrhythmias in Structurally Normal Hearts: A 2-Patient Report.

Authors:  Lennart J de Vries; Tamas Géczy; Tamas Szili-Torok
Journal:  J Cardiovasc Pharmacol       Date:  2017-10       Impact factor: 3.105

Review 9.  New insights into the role of melatonin in diabetic cardiomyopathy.

Authors:  Keming Huang; Xianling Luo; Yi Zhong; Li Deng; Jian Feng
Journal:  Pharmacol Res Perspect       Date:  2022-02

10.  Expression of Melatonin Receptor 1 in Rat Mesenteric Artery and Perivascular Adipose Tissue and Vasoactive Action of Melatonin.

Authors:  Lubos Molcan; Andreas Maier; Anna Zemančíková; Katharina Gelles; Jozef Török; Michal Zeman; Isabella Ellinger
Journal:  Cell Mol Neurobiol       Date:  2020-07-30       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.